Skip to main content
. 2022 Jun 6;38(6):455–462. doi: 10.1089/aid.2021.0135

FIG. 2.

FIG. 2.

TFV-DP in DBS in patients categorized by (a) UTRA results and (b) VL failure category (above or below 400 copies/mL). There were significantly lower TFV-DP concentrations in participants who were UTRA negative (p = .02), but the difference in TFV-DP between participants with VF versus suppression was not significant (p = .5). DBS, dried blood spots; TFV-DP, tenofovir diphosphate; UTRA, urine tenofovir rapid assay; VF, virologic failure; VL, viral load.